مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

163
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

87
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Efficacy of high-dose vitamin D3 supplementation in vitamin D deficient pregnant women with multiple sclerosis: Preliminary findings of a randomized-controlled trial

Pages

  67-73

Abstract

 Background: The aim of this preliminary study was to assess the safety and efficacy of high-dose oral Vitamin D3 supplementation during Pregnancy in women with Multiple Sclerosis (MS) in Isfahan, Iran. Methods: In a single center open-label randomized, controlled clinical Phase I/II pilot study, 15 pregnant women with confirmed MS with low serum 25-hydroxyVitamin D (25(OH)D) levels were randomly allocated to receive either 50, 000 IU/week Vitamin D3 or routine care from 12 to 16 weeks of gestation till delivery. The main outcome measures were mean change in serum 25(OH)D levels, expanded disability status scale (EDSS) score, and number of relapse events during Pregnancy and within 6 months after delivery. Results: Average serum 25(OH)D level at the end of trial in Vitamin D3 supplemented group was higher than routine care group (33. 7 ng/mL vs. 14. 6 ng/ml, P < 0. 050). In Vitamin D3 group, the mean EDSS did not changed 6 months after delivery (P > 0. 050), whereas in routine care group, the mean EDSS increased from 1. 3 (0. 4) to 1. 7 (0. 6) (P < 0. 070). Women in Vitamin D3 group appeared to have fewer relapse events during Pregnancy and within 6 months after delivery. No significant adverse events occurred. Conclusion: Adding high dose Vitamin D3 supplementation during Pregnancy to routine care of women with MS had significant effect on the serum 25(OH)D levels, EDSS and number of relapse events during Pregnancy and within 6 months after delivery.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    ETEMADIFAR, MASOUD, & JANGHORBANI, MOHSEN. (2015). Efficacy of high-dose vitamin D3 supplementation in vitamin D deficient pregnant women with multiple sclerosis: Preliminary findings of a randomized-controlled trial. CURRENT JOURNAL OF NEUROLOGY (IRANIAN JOURNAL OF NEUROLOGY), 14(2), 67-73. SID. https://sid.ir/paper/715639/en

    Vancouver: Copy

    ETEMADIFAR MASOUD, JANGHORBANI MOHSEN. Efficacy of high-dose vitamin D3 supplementation in vitamin D deficient pregnant women with multiple sclerosis: Preliminary findings of a randomized-controlled trial. CURRENT JOURNAL OF NEUROLOGY (IRANIAN JOURNAL OF NEUROLOGY)[Internet]. 2015;14(2):67-73. Available from: https://sid.ir/paper/715639/en

    IEEE: Copy

    MASOUD ETEMADIFAR, and MOHSEN JANGHORBANI, “Efficacy of high-dose vitamin D3 supplementation in vitamin D deficient pregnant women with multiple sclerosis: Preliminary findings of a randomized-controlled trial,” CURRENT JOURNAL OF NEUROLOGY (IRANIAN JOURNAL OF NEUROLOGY), vol. 14, no. 2, pp. 67–73, 2015, [Online]. Available: https://sid.ir/paper/715639/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button